PLK1 and uterine carcinoma: Through The Cancer Genome Atlas (TCGA) and xenograft analysis, we further correlate our biochemical and cytological studies with pathological consequences: T291A and T291N mutations and PLK1 upregulation promote uterine carcinoma.